Key Points

The Union Cabinet has approved a landmark Rs 3,000 crore Biomedical Research Career Programme, marking a significant investment in India's scientific ecosystem. This Phase III initiative will run from 2025-2031 and focuses on nurturing top-tier scientific talent across various research domains. The programme aims to generate high-impact publications, support patentable discoveries, and increase research opportunities, especially for women scientists. By fostering interdisciplinary research and international collaborations, the initiative seeks to position India as a global leader in biomedical sciences.

Key Points: Modi Approves Rs 3,000 Cr Biomedical Research Programme

  • Cabinet launches strategic 6-year biomedical research initiative
  • Programme targets training over 2,000 students and researchers
  • Collaborative effort between Department of Biotechnology and Wellcome Trust UK
  • Aims to strengthen scientific capacity and reduce regional research disparities
3 min read

Cabinet okays Phase III of Biomedical Research Career Programme for an outlay of Rs 3,000 cr

Cabinet green-lights Phase III of Biomedical Research Career Programme, boosting scientific talent and innovation across India

"Phases I and II positioned India as an emerging hub for biomedical science of international standing - Cabinet Communique"

New Delhi, Oct 1

The Union Cabinet, chaired by Prime Minister Narendra Modi, on Wednesday approved Phase III of the Biomedical Research Career Programme (BRCP) for an outlay of Rs 3,000 crore for six years.

The Phase III programme, beginning 2025-26 to 2030-31, is being implemented in partnership between the Department of Biotechnology (DBT) and the Wellcome Trust (WT), UK, and the SPV, India Alliance.

"Fellowships and grants have been approved till 2030-31, at a total cost of Rs. 1,500 crore with DBT and WT, UK contributing Rs 1,000 crore and Rs 500 crore respectively," according to a Cabinet Communique.

The programme, in alignment with Viksit Bharat goal, aims to foster skills and innovation, as well as to nurture top-tier scientific talent for cutting-edge biomedical research, and promote interdisciplinary research for translational innovation.

It will also strengthen systems supporting high-quality research and reduce regional disparities in scientific capacity to create world-class biomedical research capacity with global impact.

The Cabinet launched Phase I of the programme in 2008-2009 and offered research fellowships, based in India, for biomedical research at world-class standards. Subsequently, Phase II was implemented in 2018/19 with an expanded portfolio.

"Phases I and II positioned India as an emerging hub for biomedical science of international standing. India's rising investment in science and its growing role in the global knowledge economy demand a new phase of strategic effort. Building on the gains of earlier Phases, Phase-III will invest in talent, capacity, and translation aligned with national priorities and global benchmarks," the Communique said.

The Phase-III will implement programmes such as early career and intermediate research fellowships in basic, clinical, and public health. These are globally recognised and tailored for the formative stages of a scientist's research career.

It will also offer a collaborative grants programme, which includes career development grants and catalytic collaborative grants for 2-3 investigator teams for early and mid-senior career researchers, respectively, with a strong research track record in India.

The research management programmes will also be rolled out to strengthen core research endeavours.

Further, Phase III will also focus on strengthening mentorship, networking, public engagement, and developing new and innovative national and international partnerships.

Together, the research fellowships, collaborative grants, and the research management programme with pan-India implementation will drive scientific excellence, skills development, collaboration, and knowledge exchange.

"Expected outcomes include training over 2,000 students and postdoctoral fellows, generating high-impact publications, enabling patentable discoveries, earning peer recognition, enabling a 10-15 per cent increase in support to women, 25-30 per cent of collaborative programmes to approach TRL4 and above, and an expanded footprint of activities and engagement in Tier-2/3 settings," the Communique said.

- IANS

Share this article:

Reader Comments

R
Rohit P
While the initiative is good, I hope the implementation is transparent. We've seen many schemes where funds don't reach deserving candidates. Proper monitoring committees should be established to ensure merit-based selection.
A
Ananya R
The 10-15% increase in support for women researchers is a welcome step! More women in STEM will definitely boost innovation. Hope this inspires young girls across India to pursue careers in biomedical research. 👩‍🔬
D
David E
The partnership with Wellcome Trust UK is strategic. International collaborations like this will help Indian researchers gain global exposure and bring world-class standards to our institutions. Good move!
V
Vikram M
Training 2000+ students and postdocs is ambitious but achievable. The focus on Tier-2/3 cities will help decentralize research excellence. Hope this creates more research hubs beyond the usual metros.
S
Sarah B
The emphasis on translational research and patentable discoveries is crucial. India needs to move from publishing papers to creating actual healthcare solutions. This could be a game-changer for our medical innovation ecosystem.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50